What is King Pharmaceuticals's operating cash flow?

King Pharmaceuticals (KG) reported operating cash flow of -$15.13M in Q1 2026.

How has King Pharmaceuticals's operating cash flow changed year-over-year?

King Pharmaceuticals's operating cash flow decreased by 1627.5% year-over-year, from -$876K to -$15.13M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

King Pharmaceuticals KG Operating Cash Flow

Operating Cash Flow at other companies

Arch Capital GroupACGL

$1.19B-18.5%

Everest GroupEG

$649M-30.1%

SiriusPointSPNT

$141.9M+260%

KKR & Co.KKR

$1.75B-31.5%

Skyward Specialty Insurance Group, Inc.SKWD

$116.54M+20.4%

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's operating cash flow?: King Pharmaceuticals (KG) reported operating cash flow of -$15.13M in Q1 2026.
How has King Pharmaceuticals's operating cash flow changed year-over-year?: King Pharmaceuticals's operating cash flow decreased by 1627.5% year-over-year, from -$876K to -$15.13M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.